All In Biotech

Free tool

FAERS Monitor: Phexx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208352 or its brand name (Phexx, Citric Acid, Lactic Acid, Potassium Bitartrate). Reports on generic versions are filed under their own applications.

Reports

181

Serious

71

39% of reports

Hospitalization

8

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective59
  • pregnancy59
  • abortion spontaneous19
  • vulvovaginal burning sensation18
  • pregnancy on contraceptive14
  • product administration error14
  • complication of device insertion6
  • expired product administered6
  • nausea6
  • vaginal discharge6
  • vaginal haemorrhage6
  • abdominal pain5
  • burning sensation5
  • ectopic pregnancy5
  • vulvovaginal pain5

Reports by year received

View as table
YearReports
20201
202136
202261
202335
202429
20258
202611

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,978 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pregnancy on contraceptiveSignal141125.4678.714,484
vulvovaginal burning sensationSignal18343.7221.55,797
pregnancySignal59343.5278.419,765
ectopic pregnancySignal5189.379.7756
vulvovaginal painSignal5120.750.8480
product administration errorSignal1480.648.71,022
vaginal dischargeSignal668.931.4337
abortion spontaneousSignal1955.136.0958
complication of device insertionSignal635.116.0166
expired product administeredSignal621.09.695
vaginal haemorrhageSignal616.17.371
burning sensationSignal58.33.525
drug ineffectiveSignal595.24.2209
abdominal pain52.51.13
nausea60.90.40

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.